India to start first spherical of large Covid vaccination programme


However issues have been raised over the efficacy of Covaxin as a result of the

regulator’s emergency approval got here earlier than the completion of Section 3 scientific trials. The regulator and the producer have mentioned the vaccine is secure, and that the efficacy information can be obtainable by February.



Source link

Please follow and like us:

Leave a Reply

Your email address will not be published. Required fields are marked *